1344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumors
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
_version_ | 1797629540069015552 |
---|---|
author | Christine Lee Nicole Grigaitis Nicole Martinez Maria Fumagalli Chang Cui Ravindra Gujar Arezoo Arjmand Catherine Reardon Kelly Schoenfelt Sonia Feau Lev Becker |
author_facet | Christine Lee Nicole Grigaitis Nicole Martinez Maria Fumagalli Chang Cui Ravindra Gujar Arezoo Arjmand Catherine Reardon Kelly Schoenfelt Sonia Feau Lev Becker |
author_sort | Christine Lee |
collection | DOAJ |
first_indexed | 2024-03-11T10:54:52Z |
format | Article |
id | doaj.art-095ee82a6ed6457695deff934997acac |
institution | Directory Open Access Journal |
issn | 2051-1426 |
language | English |
last_indexed | 2024-03-11T10:54:52Z |
publishDate | 2023-11-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | Journal for ImmunoTherapy of Cancer |
spelling | doaj.art-095ee82a6ed6457695deff934997acac2023-11-13T10:05:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.13441344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumorsChristine Lee0Nicole Grigaitis1Nicole Martinez2Maria Fumagalli3Chang Cui4Ravindra Gujar5Arezoo Arjmand6Catherine Reardon7Kelly Schoenfelt8Sonia Feau9Lev Becker10Office of the Commissioner, Office of Minority Health and Health Equity, US Food and Drug Administration, Silver Spring, Maryland, USAOncoMyx Therapeutics, Phoenix, AZ, United StatesCenter for Biomedical Ethics, Stanford University School of Medicine, Stanford, California, USAHibercell, Inc., Roseville, MN, United States1Onchilles Pharma, San Diego, CA, USA1Onchilles Pharma, San Diego, CA, USA1Onchilles Pharma, San Diego, CA, USA2University of Chicago, Chicago, IL, USA2University of Chicago, Chicago, IL, USA1Onchilles Pharma, San Diego, CA, USA1Onchilles Pharma, San Diego, CA, USA |
spellingShingle | Christine Lee Nicole Grigaitis Nicole Martinez Maria Fumagalli Chang Cui Ravindra Gujar Arezoo Arjmand Catherine Reardon Kelly Schoenfelt Sonia Feau Lev Becker 1344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumors Journal for ImmunoTherapy of Cancer |
title | 1344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumors |
title_full | 1344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumors |
title_fullStr | 1344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumors |
title_full_unstemmed | 1344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumors |
title_short | 1344 N17350 combines selective cancer killing with adaptive immune activation to eradicate tumors |
title_sort | 1344 n17350 combines selective cancer killing with adaptive immune activation to eradicate tumors |
work_keys_str_mv | AT christinelee 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors AT nicolegrigaitis 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors AT nicolemartinez 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors AT mariafumagalli 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors AT changcui 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors AT ravindragujar 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors AT arezooarjmand 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors AT catherinereardon 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors AT kellyschoenfelt 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors AT soniafeau 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors AT levbecker 1344n17350combinesselectivecancerkillingwithadaptiveimmuneactivationtoeradicatetumors |